AVEO Pharmaceuticalsâ Oral, Triple VEGF Receptor Inhibitor AV-951 Shows Robust Activity in Patients with Advanced ... Centre Daily Times Wed, 25 Feb 2009 05:55 AM PST AVEO Pharmaceuticals, Inc., a biopharmaceutical company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced positive interim results from a 272-patient Phase 2 clinical trial of AV-951, a novel, oral, triple VEGF receptor inhibitor, in patients with advanced renal cell carcinoma (RCC). As assessed by ... | Doctors Back Wider Consideration Of Prostate Drug KFSM Ft. Smith-Fayetteville Wed, 25 Feb 2009 05:54 AM PST Leading medical groups are advising millions of healthy men who are regularly screened for prostate cancer to consider taking a drug to prevent it. | More Evidence Links Alcohol to Cancer In Women KFSM Ft. Smith-Fayetteville Wed, 25 Feb 2009 05:54 AM PST A study of nearly 1.3 million middle-aged British women offers more evidence that moderate alcohol consumption increases the risk of some cancers. | Jade 'begged doctors to help her die' Hertfordshire Mercury Wed, 25 Feb 2009 05:53 AM PST FORMER Hertford salon owner and Upshire resident Jade Goody pleaded with doctors to help her die after being told her cancer was terminal, it has been reported. | Another Gift for Daffodil Place Voice of the Common Man Wed, 25 Feb 2009 05:51 AM PST Another major shot in the arm for Daffodil Place. The TD Bank Financial Group announced they will kick off 2009 with a gift of $25,000 for the home away from home for cancer patients and their families. | Regular Light Alcohol Drinking Raises Cancer Risk For Women Medical News Today Wed, 25 Feb 2009 05:27 AM PST Women who regularly consume one or two alcoholic drinks each day have a notably higher chance of developing cancers compared to women who do not drink regularly, says a new report from Cancer Research UK. The risk increases significantly for breast, liver and rectum cancers, says the report. | Men urged to ask about prostate drug Calgary Sun Wed, 25 Feb 2009 05:16 AM PST Men who are regularly screened for prostate cancer but show no symptoms should talk to their doctors about taking a hormone-inhibiting drug that may prevent the disease, new U.S. guidelines recommend. | | |
|
No comments:
Post a Comment